DARE Daré Bioscience, Inc.

0.7900USD-5.17%Mkt Cap: 15.54M $P/E: —

Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide…

Key Statistics

Company
Market Cap15.54M USD
Enterprise Value6.88M USD
Revenue (TTM)1.37M USD
Gross Profit734.39K USD
Net Income (TTM)-13.40M USD
Revenue/Share0.10 USD
Last Price0.7900 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees21
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.01
PEG—
EV/EBITDA-0.77
EV/Revenue5.04
P/S12.00
P/B-22.52
EPS (TTM)-0.71
EPS (Forward)-0.41
52W Range
0.69003% of range3.780
52W High3.780 USD
52W Low0.6900 USD
Profitability
Gross Margin71.29%
Oper. Margin-1582.53%
EBITDA Margin0.00%
Profit Margin-1300.66%
ROE-471.37%
ROA-41.26%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.89M USD
CapEx (TTM)385.28K USD
FCF Margin-505.74%
FCF Yield-44.46%
Net Debt-5.85M USD
Net Debt/EBITDA0.65
Balance Sheet
Debt/Equity0.93
Current Ratio0.99
Quick Ratio0.75
Book Value/Sh-0.04 USD
Cash/Share0.82 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJul 20, 2017
Splits
Last Split1:12
Split DateJul 1, 2024
Analyst Consensus
Rating—
Target (Mean)8.333 USD
Upside (mean)+954.9%
Target Range5.000 USD – 12.00 USD
5.000+954.9% to mean12.00
# Analysts3
Ownership
Shares Out.19.67M
Float12.98M
Insiders12.08%
Institutions13.37%
Short Interest
Short Ratio1.7d
Short % Float4.39%
Short % Out.4.37%
Shares Short859.25K
Short (prev mo.)1.17M
Technical
SMA 500.9289 (-14.9%)
SMA 2001.708 (-53.7%)
Beta1.01
S&P 52W Chg16.45%
Avg Vol (30d)368.49K
Avg Vol (10d)299.25K
Technical Indicators
RSI (14)41.2
MACD-0.0470
MACD Signal-0.0747
MACD Hist.+0.0277
BB Upper0.8906 USD
BB Middle0.7826 USD
BB Lower0.6747 USD
BB Width27.60%
ATR (14)0.0760 USD
Vol Ratio (20d)0.44x